CHLORPHENIRAMINE MALEATE Drug Patent Profile

When do Chlorpheniramine Maleate patents expire, and what generic alternatives are available?

Chlorpheniramine Maleate is a drug marketed by Aurolife Pharma Llc, Bel Mar, Elkins Sinn, Watson Labs, Pharm Assoc, Avanthi Inc, Anabolic, Bell Pharma, Impax Labs, Ivax Sub Teva Pharms, Kv Pharm, Lederle, Newtron Pharms, Panray, Pharmavite, Pharmeral, Pioneer Pharms, Purepac Pharm, Pvt Form, Roxane, Sun Pharm Industries, Vitarine, and West Ward. and is included in thirty NDAs.

The generic ingredient in CHLORPHENIRAMINE MALEATE is chlorpheniramine maleate. There is one drug master file entry for this compound. Two suppliers are listed for this compound. Additional details are available on the chlorpheniramine maleate profile page.

DrugPatentWatch^® Litigation and Generic Entry Outlook for Chlorpheniramine Maleate

A generic version of CHLORPHENIRAMINE MALEATE was approved as chlorpheniramine maleate by AVANTHI INC on May 13^th, 2009.

Summary for CHLORPHENIRAMINE MALEATE

US Patents:	0
Applicants:	23
NDAs:	30
Finished Product Suppliers / Packagers:	2
Raw Ingredient (Bulk) Api Vendors:	84
Clinical Trials:	9
Patent Applications:	5,353
Drug Prices:	Drug price information for CHLORPHENIRAMINE MALEATE
DailyMed Link:	CHLORPHENIRAMINE MALEATE at DailyMed

See drug prices for CHLORPHENIRAMINE MALEATE

See drug sales revenues for CHLORPHENIRAMINE MALEATE

Recent Clinical Trials for CHLORPHENIRAMINE MALEATE

Identify potential brand extensions & 505(b)(2) entrants

Sponsor	Phase
Dr. Ferrer BioPharma	Phase 2/Phase 3
Hospital CEMESA Cortés, San Pedro Sula, Honduras	Phase 2/Phase 3
Marcos Sanchez-Gonzalez, MD, PhD	Phase 2/Phase 3

See all CHLORPHENIRAMINE MALEATE clinical trials

Pharmacology for CHLORPHENIRAMINE MALEATE

Drug Class	Histamine-1 Receptor Antagonist
Mechanism of Action	Histamine H1 Receptor Antagonists

Medical Subject Heading (MeSH) Categories for CHLORPHENIRAMINE MALEATE

Anti-Allergic Agents

Antipruritics

Histamine H1 Antagonists

Anatomical Therapeutic Chemical (ATC) Classes for CHLORPHENIRAMINE MALEATE

D04AA	Antihistamines for topical use
D04A	ANTIPRURITICS, INCL. ANTIHISTAMINES, ANESTHETICS, ETC.
D04	ANTIPRURITICS, INCL. ANTIHISTAMINES, ANESTHETICS, ETC.
D	Dermatologicals

R06AB	Substituted alkylamines
R06A	ANTIHISTAMINES FOR SYSTEMIC USE
R06	ANTIHISTAMINES FOR SYSTEMIC USE
R	Respiratory system

US Patents and Regulatory Information for CHLORPHENIRAMINE MALEATE

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Watson Labs	CHLORPHENIRAMINE MALEATE	chlorpheniramine maleate	TABLET;ORAL	080791-001	Approved Prior to Jan 1, 1982		DISCN	No	No
Watson Labs	CHLORPHENIRAMINE MALEATE	chlorpheniramine maleate	TABLET;ORAL	085139-001	Approved Prior to Jan 1, 1982		DISCN	No	No
Aurolife Pharma Llc	CHLORPHENIRAMINE MALEATE	chlorpheniramine maleate	CAPSULE, EXTENDED RELEASE;ORAL	070797-001	Aug 12, 1988		DISCN	No	No
Panray	CHLORPHENIRAMINE MALEATE	chlorpheniramine maleate	TABLET;ORAL	083243-001	Approved Prior to Jan 1, 1982		DISCN	No	No
Roxane	CHLORPHENIRAMINE MALEATE	chlorpheniramine maleate	TABLET;ORAL	080626-001	Approved Prior to Jan 1, 1982		DISCN	No	No
Pharm Assoc	CHLORPHENIRAMINE MALEATE	chlorpheniramine maleate	SYRUP;ORAL	087520-001	Feb 10, 1982		DISCN	No	No
Watson Labs	CHLORPHENIRAMINE MALEATE	chlorpheniramine maleate	INJECTABLE;INJECTION	083593-001	Approved Prior to Jan 1, 1982		DISCN	No	No